Lumexa Imaging Holdings, Inc. Common Stock (LMRI) is a publicly traded the market company. As of July 29, 2026, LMRI trades at $10.90 with a market cap of $1.06B and a P/E ratio of 548.60. LMRI moved +0.00% today. Year to date, LMRI is -40.70%; over the trailing twelve months it is flat. Its 52-week range spans $6.45 to $19.45. Analyst consensus is strong buy with an average price target of $15.75. Rallies surfaces LMRI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for LMRI, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $10.90 |
| Market Cap | $1.06B |
| P/E Ratio | 548.60 |
| EPS | $0.02 |
| Dividend Yield | 0.00% |
| 52-Week High | $19.45 |
| 52-Week Low | $6.45 |
| Volume | 2.40K |
| Avg Volume | 0 |
| Revenue (TTM) | $252.54M |
| Net Income | $1.72M |
| Gross Margin | 0.00% |
5 analysts cover LMRI: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $15.75.